BlueTree Allied Angels

Type

Angel Group/Syndicate

Status

Active

Location

Wexford, United States

Total investments

40

Average round size

2M

Portfolio companies

28

Rounds per year

2.00

Lead investments

2

Follow on index

0.28

Exits

5

Stages of investment
Early Stage Venture
Areas of investment
BiotechnologySoftwareInformation TechnologyArtificial IntelligenceHealth CareEnterprise SoftwareMedical DeviceMedicalLife ScienceTherapeutics

Summary

BlueTree Allied Angels appeared to be the VC, which was created in 2003. The leading representative office of defined VC is situated in the Wexford. The company was established in North America in United States.

The important activity for fund was in 2014. Despite it in 2019 the fund had an activity. The top amount of exits for fund were in 2018. This BlueTree Allied Angels works on 14 percentage points less the average amount of lead investments comparing to the other organizations. The usual things for fund are deals in the range of 1 - 5 millions dollars. The fund is constantly included in less than 2 investment rounds annually. Speaking about the real fund results, this VC is 9 percentage points less often commits exit comparing to other organizations.

The current fund was established by Catherine Mott. We also calculated 3 valuable employees in our database.

Among the most popular fund investment industries, there are Medical, Consumer. The fund has no exact preference in a number of founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight Cognition Therapeutics, ALung Technologies, NewCare Solutions. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund.

The typical case for the fund is to invest in rounds with 3-4 participants. Despite the BlueTree Allied Angels, startups are often financed by Pittsburgh Life Sciences Greenhouse, North Coast Angel Fund, JumpStart Inc.. The meaningful sponsors for the fund in investment in the same round are Innovation Works, Pittsburgh Life Sciences Greenhouse, New York Angels. In the next rounds fund is usually obtained by Pittsburgh Equity Partners, Tech Coast Angels, Sofia Fund.

Show more

Investor highlights

Stage focus
Seed

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
40
Lead investments
2
Exits
5
Rounds per year
2.00
Follow on index
0.28
Investments by industry
  • Software (14)
  • Health Care (13)
  • Biotechnology (11)
  • Therapeutics (10)
  • Medical Device (8)
  • Show 66 more
Investments by region
  • United States (39)
Peak activity year
2014

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
11
Avg. valuation at time of investment
2M
Group Appearance index
0.95
Avg. company exit year
9
Avg. multiplicator
1.62

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
CytoAgents 12 May 2023 Biotechnology Early Stage Venture 7M United States, Pennsylvania, Pittsburgh
Lineavi 01 Jan 2015 Fitness, Health Care, Wellness, Law Enforcement Seed 0 Berlin, Germany
TalkShoe 26 Jun 2008 Messaging, Apps, Communities, Music, Social Media, Digital Media, Podcast Seed 1M United States, Pennsylvania
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.